Nahzli Dilek

1.5k total citations
27 papers, 1.1k citations indexed

About

Nahzli Dilek is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Nahzli Dilek has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Nahzli Dilek's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (9 papers). Nahzli Dilek is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (9 papers). Nahzli Dilek collaborates with scholars based in France, Switzerland and United States. Nahzli Dilek's co-authors include Bernard Vanhove, Csaba Szabó, Gilles Blancho, Tracy Toliver‐Kinsky, Andreas Papapetropoulos, Nicolas Poirier, Romain Vuillefroy de Silly, Caroline Mary, Jérémy Hervouet and Kelly Ascenção and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Nahzli Dilek

27 papers receiving 1.1k citations

Peers

Countries citing papers authored by Nahzli Dilek

Since Specialization

Citations

This map shows the geographic impact of Nahzli Dilek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahzli Dilek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahzli Dilek more than expected).

Fields of papers citing papers by Nahzli Dilek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahzli Dilek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahzli Dilek. The network helps show where Nahzli Dilek may publish in the future.

Co-authorship network of co-authors of Nahzli Dilek

This figure shows the co-authorship network connecting the top 25 collaborators of Nahzli Dilek. A scholar is included among the top collaborators of Nahzli Dilek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahzli Dilek. Nahzli Dilek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological induction of mesenchymal-epithelial transition via inhibition of H2S biosynthesis and consequent suppression of ACLY activity in colon cancer cells 2021 ·Pharmacological Research ·Kelly Ascenção, Nahzli Dilek, Fiona Augsburger, Theodora Panagaki, Karim Zuhra, Csaba Szabó	51
2	Cystathionine‐gamma‐lyase overexpression in T cells enhances antitumor effect independently of cysteine autonomy 2021 ·Cancer Science ·(unknown), (unknown), (unknown), Emmanuel Mérieau, Gaëlle Bériou, Tuan Huy Nguyen, Ahmed Abidi, Nahzli Dilek, (unknown), Jérémie Poschmann, Olivier Michielin, Romain Vuillefroy de Silly, Bernard Vanhove, Cédric Louvet	14
3	Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors 2021 ·Journal of Medicinal Chemistry ·Ute F. Röhrig, Somi Reddy Majjigapu, A. Reynaud, Florence Pojer, Nahzli Dilek, Patrick Reichenbach, Kelly Ascenção, Melita Irving, George Coukos, Pierre Vogel, Olivier Michielin, Vincent Zoete	13
4	Hydrogen sulfide: An endogenous regulator of the immune system 2020 ·Pharmacological Research ·Nahzli Dilek, Andreas Papapetropoulos, Tracy Toliver‐Kinsky, Csaba Szabó	216
5	Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics in Murine Colon Cancer Cells 2020 ·Biomolecules ·Fiona Augsburger, Elisa B. Randi, (unknown), Kelly Ascenção, Nahzli Dilek, Csaba Szabó	52
6	SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells 2019 ·American Journal of Transplantation ·Sabrina Pengam, Justine Durand, Claire Usal, Vanessa Gauttier, Nahzli Dilek, Bernard Martinet, (unknown), Caroline Mary, Virginie Thépenier, Géraldine Teppaz, Karine Renaudin, Gilles Blancho, Bernard Vanhove, Nicolas Poirier	34
7	Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel 2017 ·Frontiers in Immunology ·Melita Irving, Romain Vuillefroy de Silly, Kirsten Scholten, Nahzli Dilek, George Coukos	63
8	In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI 2016 ·PLoS ONE ·Christine R. Gonzales, Hikari A. I. Yoshihara, Nahzli Dilek, Julie Leignadier, Melita Irving, Pascal Miéville, Lothar Helm, Olivier Michielin, Juerg Schwitter	38
9	1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2) 2016 ·Bioorganic & Medicinal Chemistry Letters ·Ute F. Röhrig, Somi Reddy Majjigapu, Daniela Caldelari, Nahzli Dilek, Patrick Reichenbach, Kelly Ascenção, Melita Irving, George Coukos, Pierre Vogel, Vincent Zoete, Olivier Michielin	34
10	Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates 2015 ·The Journal of Immunology ·Nicolas Poirier, (unknown), Caroline Mary, Jérémy Hervouet, David Minault, Paul Baker, (unknown), Stéphanie Le Bas‐Bernardet, Nahzli Dilek, Lyssia Belarif, E. Cassagnau, Linda Scobie, Gilles Blancho, Bernard Vanhove	22
11	FR104, an Antagonist Anti-CD28 Monovalent Fab’ Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft 2014 ·American Journal of Transplantation ·Nicolas Poirier, Nahzli Dilek, Caroline Mary, (unknown), Flora Coulon, Julien Branchereau, X. Tillou, (unknown), Sabrina Pengam, Véronique Nerrière‐Daguin, Jérémy Hervouet, David Minault, Stéphanie Le Bas‐Bernardet, Karine Renaudin, Bernard Vanhove, Gilles Blancho	69
12	Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells 2013 ·PLoS ONE ·Nahzli Dilek, Nicolas Poirier, Philippe Hulin, Flora Coulon, Caroline Mary, (unknown), Henri Vié, Béatrice Clemenceau, Gilles Blancho, Bernard Vanhove	54
13	Antagonist properties of monoclonal antibodies targeting human CD28 2013 ·mAbs ·Caroline Mary, Flora Coulon, Nicolas Poirier, Nahzli Dilek, Bernard Martinet, Gilles Blancho, Bernard Vanhove	18
14	Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody 2012 ·American Journal of Transplantation ·Nicolas Poirier, Caroline Mary, Nahzli Dilek, Jérémy Hervouet, David Minault, Gilles Blancho, Bernard Vanhove	56
15	Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance 2012 ·Frontiers in Immunology ·Nahzli Dilek, Romain Vuillefroy de Silly, Gilles Blancho, Bernard Vanhove	72
16	Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model 2012 ·Transplant Immunology ·Mathieu Angin, Nicolas Poirier, Nahzli Dilek, Caroline Le Guiner, Alice Toromanoff, Antoine Blancher, Yan Chérel, Jack‐Yves Deschamps, X. Tillou, Karine Renaudin, David Minault, Jérémy Hervouet, Gilles Blancho, Bernard Vanhove, Ignacio Anegón, Brigitte Le Mauff	4
17	Preclinical Efficacy and Immunological Safety of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in Humanized Mice Models 2012 ·Transplantation ·Nicolas Poirier, Nahzli Dilek, Caroline Mary, Bernard Vanhove	1
18	Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain 2012 ·Journal of Translational Medicine ·Caroline Mary, Flora Coulon, Nicolas Poirier, Nahzli Dilek, Bernard Martinet, Gilles Blancho, Bernard Vanhove	1
19	Xenotransplantation of Galactosyl-Transferase Knockout, CD55, CD59, CD39, and Fucosyl-Transferase Transgenic Pig Kidneys Into Baboons 2011 ·Transplantation Proceedings ·Stéphanie Le Bas‐Bernardet, X. Tillou, Nicolas Poirier, Nahzli Dilek, Mathias Chatelais, Julie Devallière, Béatrice Charreau, David Minault, Jérémy Hervouet, Karine Renaudin, Claire Crossan, Linda Scobie, Peter J. Cowan, A. J. F. D'Apice, Cesare Galli, Emanuele Cozzi, Jean‐Paul Soulillou, Bernard Vanhove, Gilles Blancho	52
20	Inducing CTLA-4–Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation 2010 ·Science Translational Medicine ·Nicolas Poirier, Agnes M. Azimzadeh, Tianshu Zhang, Nahzli Dilek, Caroline Mary, Bao N. Nguyen, X. Tillou, Guosheng Wu, (unknown), Jérémy Hervouet, Bernard Martinet, Flora Coulon, Emma Allain‐Launay, Georges Karam, Jean-Paul Soulillou, Richard N. Pierson, Gilles Blancho, Bernard Vanhove	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact